Recent News

• 06.13.2025 - 23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
• 06.13.2025 - 23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
• 05.27.2025 - 23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
• 05.27.2025 - 23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
• 05.19.2025 - Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
• 05.19.2025 - Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale

Recent Filings

• 06.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.11.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 06.06.2025 - EFFECT Notice of Effectiveness
• 06.06.2025 - 25 Notification of the removal from listing and registration of matured, redeemed or retired securities
• 06.03.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 06.03.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 06.03.2025 - RW Registration Withdrawal Request
• 06.03.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 06.03.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 06.03.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments